California State Teachers Retirement System trimmed its holdings in Rockwell Medical, Inc. (NASDAQ:RMTI) by 10.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 84,877 shares of the company’s stock after selling 9,500 shares during the quarter. California State Teachers Retirement System owned about 0.16% of Rockwell Medical worth $673,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. boosted its stake in Rockwell Medical by 4.9% during the 1st quarter. Vanguard Group Inc. now owns 1,990,057 shares of the company’s stock valued at $12,458,000 after purchasing an additional 93,589 shares in the last quarter. Geode Capital Management LLC boosted its stake in Rockwell Medical by 9.7% during the 1st quarter. Geode Capital Management LLC now owns 371,700 shares of the company’s stock valued at $2,326,000 after purchasing an additional 32,964 shares in the last quarter. KCG Holdings Inc. bought a new position in Rockwell Medical during the 1st quarter valued at $111,000. Metropolitan Life Insurance Co. NY boosted its stake in Rockwell Medical by 11.3% during the 1st quarter. Metropolitan Life Insurance Co. NY now owns 42,220 shares of the company’s stock valued at $264,000 after purchasing an additional 4,287 shares in the last quarter. Finally, Cutter & CO Brokerage Inc. boosted its stake in Rockwell Medical by 6.3% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 25,325 shares of the company’s stock valued at $201,000 after purchasing an additional 1,500 shares in the last quarter. 21.37% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts have issued reports on the company. Zacks Investment Research raised Rockwell Medical from a “sell” rating to a “hold” rating in a research note on Thursday. BidaskClub raised Rockwell Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, August 23rd. Finally, Ifs Securities assumed coverage on Rockwell Medical in a research note on Monday, August 14th. They set a “strong-buy” rating and a $11.00 price target for the company.
Rockwell Medical (NASDAQ:RMTI) last issued its quarterly earnings results on Wednesday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.10). The firm had revenue of $14.63 million during the quarter, compared to analyst estimates of $13.33 million. Rockwell Medical had a negative return on equity of 46.63% and a negative net margin of 39.28%. The firm’s quarterly revenue was up 14.2% on a year-over-year basis. During the same period last year, the company posted ($0.09) EPS. equities research analysts forecast that Rockwell Medical, Inc. will post -0.44 EPS for the current year.
About Rockwell Medical
Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.
Want to see what other hedge funds are holding RMTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rockwell Medical, Inc. (NASDAQ:RMTI).
What are top analysts saying about Rockwell Medical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Rockwell Medical Inc. and related companies.